FrieslandCampina
Stories
-
FrieslandCampina registers Phase 3 trial of infant formula with bio-active ingredients
The study was first posted on ClinicalTrials.gov on October 9, 2026, and plans to enroll 387 participants with a start date of January 2027. It aims to compare growth, immune parameters, and gut health between infants receiving the investigational formula and those receiving a control formula.